140 related articles for article (PubMed ID: 18194606)
1. [Advances of vasculogenic mimicry in tumors].
Zhang SW; Sun BC
Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):694-7. PubMed ID: 18194606
[No Abstract] [Full Text] [Related]
2. [Vasculogenic mimicry--potential target for tumor therapy].
Yue WY; Chen ZP
Ai Zheng; 2006 Jul; 25(7):914-6. PubMed ID: 16831290
[TBL] [Abstract][Full Text] [Related]
3. [Research advancement of endogenous angiogenesis inhibitors].
Wu JX; Xu BL; Huang WL
Ai Zheng; 2005 Mar; 24(3):376-84. PubMed ID: 15757547
[TBL] [Abstract][Full Text] [Related]
4. Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP.
Pratheeshkumar P; Kuttan G
Eur J Pharmacol; 2011 Apr; 656(1-3):10-8. PubMed ID: 21256125
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppression through angiogenesis inhibition.
Arsham AM; Simon MC
Methods Mol Biol; 2003; 223():249-70. PubMed ID: 12777736
[No Abstract] [Full Text] [Related]
6. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
[TBL] [Abstract][Full Text] [Related]
7. Reversing effect of Lupeol on vasculogenic mimicry in murine melanoma progression.
Bhattacharyya S; Mitra D; Ray S; Biswas N; Banerjee S; Majumder B; Mustafi SM; Murmu N
Microvasc Res; 2019 Jan; 121():52-62. PubMed ID: 30381268
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive tracer techniques to characterize angiogenesis.
Haubner R
Handb Exp Pharmacol; 2008; (185 Pt 2):323-39. PubMed ID: 18626609
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis and lymphangiogenesis: highlights of the past year.
Luttun A; Carmeliet P
Curr Opin Hematol; 2004 Jul; 11(4):262-71. PubMed ID: 15314526
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic cancer therapy.
Cao Y
Semin Cancer Biol; 2004 Apr; 14(2):139-45. PubMed ID: 15018898
[TBL] [Abstract][Full Text] [Related]
11. Differential adhesion drives angiogenesis.
Dejana E; Lampugnani MG
Nat Cell Biol; 2014 Apr; 16(4):305-6. PubMed ID: 24691258
[TBL] [Abstract][Full Text] [Related]
12. [Value of angiogenesis inhibitors in tumor diseases--preclinical data]].
Berdel WE; Panse J
Onkologie; 2005 Oct; 28 Suppl 4():25-8. PubMed ID: 16205102
[No Abstract] [Full Text] [Related]
13. Angiogenesis in melanoma.
Mahabeleshwar GH; Byzova TV
Semin Oncol; 2007 Dec; 34(6):555-65. PubMed ID: 18083379
[TBL] [Abstract][Full Text] [Related]
14. Signalling pathways and adhesion molecules as targets for antiangiogenesis therapy in tumors.
Bazzoni G
Adv Exp Med Biol; 2008; 610():74-87. PubMed ID: 18593016
[No Abstract] [Full Text] [Related]
15. [Endothelial junctions: exploiting their instability in the development of biomarkers for vascular remodelling].
Bouillet L; Sidibé A; Polena H; Mannic T; Deroux A; Stidder B; Vittecoq O; Vilgrain I
Med Sci (Paris); 2014; 30(6-7):633-5. PubMed ID: 25014453
[No Abstract] [Full Text] [Related]
16. Intermedin: a novel regulator for vascular remodeling and tumor vessel normalization by regulating vascular endothelial-cadherin and extracellular signal-regulated kinase.
Zhang W; Wang LJ; Xiao F; Wei Y; Ke W; Xin HB
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2721-32. PubMed ID: 22922959
[TBL] [Abstract][Full Text] [Related]
17. Prostanoid receptor signaling relevant to tumor growth and angiogenesis.
Majima M; Amano H; Hayashi I
Trends Pharmacol Sci; 2003 Oct; 24(10):524-9. PubMed ID: 14559404
[No Abstract] [Full Text] [Related]
18. A reinforced random walk model of tumour angiogenesis and anti-angiogenic strategies.
Plank MJ; Sleeman BD
Math Med Biol; 2003 Jun; 20(2):135-81. PubMed ID: 14636027
[TBL] [Abstract][Full Text] [Related]
19. Numerical simulation of the inhibitory effect of angiostatin on metastatic tumor angiogenesis and microenvironment.
Zhao G; Yan W; Chen E; Yu X; Cai W
Bull Math Biol; 2013 Feb; 75(2):274-87. PubMed ID: 23292363
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome-independent block of angiogenesis and matrix metalloproteinases.
Toschi E; Sgadari C; Malavasi L; Bacigalupo I; Chiozzini C; Carlei D; Compagnoni D; Bellino S; Bugarini R; Falchi M; Palladino C; Leone P; Barillari G; Monini P; Ensoli B
Int J Cancer; 2011 Jan; 128(1):82-93. PubMed ID: 20617515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
